exa-cel
Vertex pharmaceuticals,CRISPR therapeutics AG
[]
vertex and crispr therapeutics present new data on more patients with longer follow-up treated with exagamglogene autotemcel (exa-cel) at the 2022 european hematology association (eha) congress #stocksmarket #pressrelease
Join us at https://t.co/9QZSYoqhvl - Stock Market News and Press Releases. #StockMarket - As an affiliate, we earn from qualifying purchases.